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Translocation between PI(4,5)P2-poor and
PI(4,5)P2-rich microdomains during store depletion
determines STIM1 conformation and Orai1 gating
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The Orai1–STIM1 current undergoes slow Ca2þ -dependent inactivation (SCDI) mediated by
the binding of SARAF to STIM1. Here we report the use of SCDI by SARAF as a probe of the
conformation and microdomain localization of the Orai1–STIM1 complex. We find that the
interaction of STIM1 with Orai1 carboxyl terminus (C terminus) and the STIM1 K-domain are
required for the interaction of SARAF with STIM1 and SCDI. STIM1–Orai1 must be in a PM/ER
microdomain tethered by E-Syt1, stabilized by septin4 and enriched in PI(4,5)P2 for
STIM1–SARAF interaction. Targeting STIM1 to PI(4,5)P2-rich and -poor microdomains
reveals that SARAF-dependent SCDI is observed only when STIM1–Orai1 are within the
PI(4,5)P2-rich microdomain. Notably, store depletion results in transient localization of
STIM1–Orai1 in the PI(4,5)P2-poor microdomain, which then translocates to the PI(4,5)P2-
rich domain. These findings reveal the role of PM/ER tethers in the regulation of Orai1
function and a mode of regulation by PI(4,5)P2 involving translocation between PI(4,5)P2
microdomains.
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C
a2þ is a unique second messenger whose cytoplasmic
concentration is determined by Ca2þ pumps and
channels. Physiological receptor-evoked Ca2þ signals
regulate virtually all cell functions on timescales from ms to
days1. At the same time, excess cytoplasmic Ca2þ ([Ca2þ ]i) is
highly toxic2,3. Most often, toxic [Ca2þ ]i is due to excessive
Ca2þ influx through the plasma membrane (PM) Ca2þ
channels. Store-operated TRPC and Orai channels are key
Ca2þ influx channels4. While TRPC channels are mostly cell
specific, all cells express the major isoform Orai1, which mediates
the Ca2þ release-activated Ca2þ (CRAC) current5. Shortly after
Orai1 is activated, it is partially inhibited by the rise in [Ca2þ ]i:
this limits Ca2þ influx and prevents Ca2þ toxicity3.
Orai1 is activated in response to Ca2þ release from the ER and
is gated by the ER Ca2þ sensor STIM1 (ref. 5). STIM1 has several
domains including an ER-resident EF hand that mediates Ca2þ
sensing6; a cytoplasmic coiled-coil domain 1 comprising an
inhibitory helix that occludes STIM1 in the resting state7,8; a
SOAR domain that activates Orai1 (refs 9,10); a CTID domain
that mediates interaction of the STIM1 inhibitor SARAF11 with
SOAR12; a C terminus linker and a polybasic domain with
multiple lysines (K-domain) that may mediate the interaction of
STIM1 with PI(4,5)P2 (ref. 13).
Store depletion results in Orai1–STIM1 clustering in ER/PM
microdomains. The nature of these domains and their role in
Ca2þ signalling is not well understood. Several recent studies
have begun to define these domains. A search for proteins that
tether the ER/PM in yeast14 identified ER-resident homologues of
mammalian extended synaptotagmins (E-Syts)15, VAP proteins,
homologues of mammalian septins16 and TMEM16 proteins. The
three mammalian E-Syts participate in lipid transfer between the
ER and PM17. Their role in ER/PM tethering depends on PM
PI(4,5)P2 and, in the case of E-Syt1, also on [Ca2þ ]I (ref. 18). The
E-Syts-formed tethers were suggested to be distinct from those
formed by STIM1–Orai1 (ref. 18). However, the use of a PM/ER
microdomain marker subsequently indicated that the receptor-
evoked Ca2þ signal forms E-Syt1-dependent tethers that recruit
the phosphatidylinositol transfer protein Nir2; this restores
PM PI(4,5)P2 levels and sustains the Ca2þ signal19. Finally,
the filamentous septins 4 and 5 were reported to shape a
PM PI(4,5)P2 microdomain around clustered Orai1–STIM1
complexes20. However, the depletion of PI(4,5)P2 does not
inhibit the activation of Orai1 by STIM1 (ref. 21). Thus, the exact
roles of PI(4,5)P2 and the ER/PM microdomain in the regulation
of Ca2þ signalling and particularly Ca2þ influx by Orai1 are not
understood.
A major regulatory modality of Orai1 is the inhibition by
[Ca2þ ]i to guard against excessive Ca2þ influx. [Ca2þ ]i inhibits
Orai1 in two ways, fast Ca2þ -dependent inactivation (FCDI) that
occurs within 10–20ms and slow Ca2þ -dependent inactivation
(SCDI) that develops in 1min of channel activation3. SCDI (and
possibly FCDI-see below) is mediated by the ER protein
SARAF11, which interacts with STIM1 (ref. 12). In the present
work, we use SCDI by SARAF as a reporter of the Orai1–STIM1
complex conformation and microdomain localization. We report
that both STIM1–Orai1 complex formation and the STIM1
K-domain are required for the interaction of SARAF with STIM1.
The STIM1–Orai1 complex must be present in a microdomain
that is tethered by E-Syt1, which contains septin4, and that is
enriched in PI(4,5)P2. Furthermore, SCDI is observed only when
the STIM1–Orai1 complex is in a PI(4,5)P2-rich microdomain.
Dynamics of the STIM1–Orai1 complex localization were
measured by following fluorescence resonance energy transfer
(FRET) between CFP-STIM1 and yellow fluorescent protein
(YFP) targeted to the PI(4,5)P2-rich and -poor domains, revealing
that the store depletion is followed by STIM1–Orai1 complex
formation in the PI(4,5)P2-poor domain when the channel is fully
active. This is in turn is followed by the translocation of the
STIM1–Orai complex to the PI(4,5)P2-rich domain, recruitment
of SARAF and SCDI. These findings identify a role for tethered
ER/PM microdomains in regulating Ca2þ influx and directing
STIM1–Orai1 conformational changes, and report on a new
mode of regulation by PI(4,5)P2.
Results
Orai1 C terminus facilitates interaction of SARAF with STIM1.
Previous work reported that SARAF mediates the SCDI of Orai1
(ref. 11). Supplementary Fig. 1a shows that SARAF also affects
FCDI. FCDI is affected by the STIM1:Orai1 ratio22,23. At a
STIM1–Orai1 expression ratio of 1:1 and 20mM EGTA in the
pipette, (to minimize FCDI and better resolve the effect of
SARAF), FCDI has mainly one component with a single time
constant t1 of 7.0±0.5ms (n¼ 3; in all results, the ± indicates
s.e.m. and n indicates the number of experiments). In the presence
of SARAF, FCDI is described best by two exponentials with time
constants t1 of 15.4±0.2 and t2 of 241±26ms (n¼ 3). The effect
of SARAF on FCDI was not examined further in this study, as here
we were interested mainly in using SCDI as readout of STIM1
conformation and localization in the PM/ER microdomain.
Orai1 was reported to facilitate the interaction of SARAF with
STIM1 (ref. 11). We extended these findings in Fig. 1a,b, which
compare the time course of STIM1–STIM1, STIM1–Orai1 and
STIM1–SARAF interaction using FRET (Fig. 1a) and co-
immunoprecipitation (Co-IP; Fig. 1b) assays. The basal FRET
efficiency of STIM1–SARAF was somewhat higher than that of
the basal FRET efficiency of STIM1–Orai1 and STIM1–STIM1
(see Supplementary Fig. 2a,b). Therefore, to better illustrate the
time course of FRET increase, Fig. 1a,c shows the normalized
FRET ratio. The results show that the STIM1–SARAF interaction
is increased minimally in the absence of Orai1. STIM1–STIM1
and STIM1–Orai1 FRET start shortly after the initiation of store
depletion. Notably, FRET (Fig. 1a) and Co-IP (Fig. 1b) show that
the STIM1–SARAF interaction is delayed by about 20–45 s.
It then progresses more slowly than the STIM1–STIM1 and
STIM1–Orai1 interactions. Several Orai1 mutants were used to
identify the Orai1 domain that facilitates the STIM1–SARAF
interaction (Fig. 1c). Orai1(D1–73), Orai1(DN) lacking the entire
Orai1 amino terminus (N terminus), constitutively active
Orai1(V102C) and channel-dead Orai1(R91W) facilitated the
STIM1–SARAF interaction. Only Orai1(L273S) with a disrupted
C terminus CCD24 failed to support the STIM1–SARAF
interaction. Figure 1e shows the Orai1-mediated CRAC current.
The current is activated by depleting ER Ca2þ by including
relatively low concentration (1.5mM) of the slow Ca2þ buffer
EGTA in the pipette solution so that SCDI can be reliably
measured. Three minutes after the initiation of store depletion,
the current was measured by including 10mM Ca2þ in the bath
solution. SARAF overexpression enhanced and its knockdown
(see Fig. 1d) markedly reduced SCDI.
These findings suggest that the STIM1–SARAF interaction is
independent of the Orai1 channel function and can take place at
basal [Ca2þ ]i and that the interaction of STIM1 with the Orai1 C
terminus CCD mediates recruitment of SARAF to the STIM1–
Orai1 complex. Recruitment of SARAF to the complex starts only
after initiation of the interaction between STIM1 and Orai1.
The STIM1 K-domain in STIM1–SARAF interaction. To
determine if STIM1 domains other than SOAR are required for
its interaction with SARAF, we tested the role of the STIM1
K-domain. Deletion of the K-domain prevented STIM1-SARAF
interaction. This was the case even before store depletion as
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evident from the reduced basal FRET efficiency. This was not due
to the interrupted STIM1–STIM1 or STIM1–Orai1 interaction
(Supplementary Fig. 1b). Importantly, while deletion of the
K-domain had no effect on the activation of Orai1 current by
STIM1 (peak currents 19.1±0.5 and 18.8±0.5 pA/pF; n¼ 4 and 6),
the deletion eliminated the effect of SARAF on SCDI (Fig. 2b).
To define the PM microdomain that interacts with the
K-domain, we first determined whether the scaffold protein
caveolin was required for normal current density and for SARAF
to mediate SCDI. The knockdown of caveolin (Supplementary
Fig. 3a) had no effect on current density but eliminated both the
STIM1–SARAF interaction and the effect of SARAF on SCDI
(Supplementary Fig. 3b,c). Hence, the STIM1–Orai1 complex
has the same current whether in a caveolin-containing domain
or outside this domain. However, the complex can only recruit
SARAF to mediate SCDI when it is within the caveolin-
containing domain. Therefore, SCDI by SARAF can function
as a probe to report the microdomain localization of the
STIM1–Orai1 complex.
Tethered PM/ER microdomain in STIM1–SARAF interaction.
It has been suggested that the K-domain interacts with PM
PI(4,5)P2 (ref. 13). Therefore, we tested the effect of depleting PM
PI(4,5)P2 with the FRB/FKBP12 rapamycin-activated system21.
The scheme in Fig. 3a illustrates the experimental system for
Figs 3 and 4 and Fig. 3b shows that the FRB/FKBP12 system
efficiently depletes cellular PI(4,5)P2. Supplementary Fig. 2c
shows that the depletion of PI(4,5)P2 reduces the basal STIM1–
SARAF interaction (reduced basal FRET efficiency). More
important, Fig. 3c shows that the depletion of PI(4,5)P2
strongly inhibits the STIM1–SARAF interaction in response to
store depletion. Significantly, as reported previously21, PI(4,5)P2
depletion had no effect on Orai1 peak current (19.8±0.04 and
20.0±0.6 pA/pF without and with PI(4,5)P2 depletion; n¼ 8 and 6),
but prevented the effect of SARAF (Fig. 3d).
It has recently been reported that filamentous septin4
participates in the formation of a PI(4,5)P2 microdomain around
Orai1 and it is required for STIM1–Orai1 clustering and Orai1
activation20. We confirmed that the knockdown of septin4
(Fig. 4a) reduced Orai1 current by 36±3%. It is unlikely that this
can be attributed solely to the disruption of a PI(4,5)P2
microdomain20, since depletion of PI(4,5)P2 did not reduce
current density. Nevertheless, Fig. 4b,c and Supplementary Fig. 2d
show that the knockdown of septin4 prevented STIM1–SARAF
interaction and the effect of SARAF on SCDI (the currents were
normalized to better demonstrate the effect of septin4 knockdown).
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Figure 1 | STIM1–Orai1 interaction is required for SARAF interaction with STIM1. (a) FRET was measured in HEK293 cells transfected with
CFP-STIM1 and YFP-STIM1, CFP-STIM1 and YFP-Orai1, CFP-STIM1 and YFP-SARAF and with (red) or without (green) HA-Orai1. Store depletion by
CPA in Ca2þ -free solution was initiated where indicated. The delay in STIM1–SARAF interaction is marked by grey rectangle. The averaged FRET
efficiencies before and after 5min treatment with CPA are shown in Supplementary Fig. 2. The images are example FRET images at the indicated conditions
before (basal) and after 5min store depletion. Scale bars, 5 mm. (b) Co-IP of STIM1 and SARAF. HEK cells were transfected with STIM1 and SARAF alone
(left blots) or with Orai1 (right blots) and were incubated in Ca2þ -free solution containing 25mM CPA for the indicated times before preparation of lysates.
The lysates were used to IP SARAF and blotted for STIM1. (c) CFP-STIM1-YFP-SARAF FRET was measured in cells expressing the indicated HA-Orai1
mutants. Scale bars in images are 5 mm. (d) HEK cells were treated with siSARAF for 48 h and analysed for expression of SARAF. (e) HEK cells were treated
with scrambled or siSARAF were transfected with Orai1, STIM1 and with or without SARAF and Orai1 current was measured by dialyzing cells with pipette
solution containing 1.5mM EGTA for 3min in Ca2þ -free bath. CRAC current was initiated by superfusing with a solution containing 10mM Ca2þ .
The residual current was inhibited with 10mM La3þ . The same protocol was used in all current measurements unless otherwise stated. The currents
were leak subtracted and normalized to the zero current to facilitate demonstrating the SCDI. Pick current density in pA/pF is given in the text. For all
FRET experiments, of the two numbers listed in parenthesis next to the traces, the first indicates the number of experiments and the second indicates
the number of cell analysed. All results (FRET and current) are given as the mean±s.e.m.
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Recent studies have shown that all three E-Syts participate in
tethering the PM to the ER18 and that E-Syt1 in particular has a
key role14,18,19. Here we tested the effects of knockdown and
overexpression of E-Syt1 on STIM1–SARAF interaction and
SCDI. Preliminary experiments showed that HEK cells express
predominantly E-Syt1 and E-Syt2 (Supplementary Fig. 4a) and
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that the knockdown of E-Syt1 increased E-Syt2 mRNA levels
(Supplementary Fig. 4b). Although E-Syt2 and E-Syt3 were
shown to localize to the peripheral ER and participate in PM/ER
tethering18, the knockdown of E-Syt2 and E-Syt3 had no effect on
SARAF-mediated SCDI (Supplementary Figs. 4c,d). In contrast,
Fig. 4d shows that the knockdown of E-Syt1 (see Supplementary
Fig. 4c) reduced basal STIM1–SARAF FRET efficiency.
Conversely, the overexpression of E-Syt1 maximally increased
STIM1–SARAF FRET efficiency and FRET efficiency did not
increase further by store depletion. The overexpression of E-Syt1
was sufficient to significantly increase STIM1–SARAF FRET
efficiency in the absence of Orai1. These findings, together with
the findings that the overexpression of E-Syt1 markedly increases
the number and size of the PM/ER microdomains18, indicate that
E-Syt1 overexpression preassembles the Orai1–STIM1–SARAF
complex and thus no further recruitment of SARAF is observed
on store depletion. Accordingly, Fig. 4e shows that knockdown
of E-Syt1 prevented the SARAF-mediated SCDI, while the
overexpression of E-Syt1 maximized SCDI to the level
observed by the overexpression of SARAF, without affecting
current density (Control 18.1±0.5, siE-Syt1 18.5±0.2, E-Syt1
18.0±0.7 pA/pF; n¼ 4, 8, 6, respectively).
Together the findings in Figs 3 and 4 suggest that tethering of
the ER to the PM by E-Syt1 forms a microdomain that requires
filamentous septins, is rich in PI(4,5)P2 and to which the
STIM1–Orai1 complex is targeted to recruit SARAF. In addition,
the findings with the knockdown of the various E-Syts suggest
some specificity in PM/ER tethers. The tethers formed by E-Syt1
recruit and regulate the function of the Orai1–STIM1 complex,
while the extensive tethers formed by E-Syt2 and E-Syt3 (ref. 18)
do not.
Targeting STIM1 to defined PM/ER sites and SCDI by SARAF.
To support the hypothesis that the STIM1–Orai1 complex is
targeted to the PI(4,5)P2-rich microdomain for interaction with
SARAF, we sought means to target STIM1 to different PM
microdomains. We achieved this using the Lyn- and Hras- or
Kras-targeting motifs. These motifs were shown to target proteins
to different PM microdomains25,26. The Kras and Hras motifs are
fused to the C terminus, but the Lyn motif is commonly attached
to the N terminus of proteins. However, since the STIM1 N
terminus resides in the ER lumen, we fused all motifs to the C
terminus of STIM1, which resulted in STIM1 targeting to the PM
using all motifs, including STIM1-Lyn and STIM1-Hras. We
determined their localization to test the specificity of the
targeting. Supplementary Fig. 5a–c shows that STIM1-Kras and
STIM1-Lyn are clustered in PM puncta in the absence of Ca2þ
store depletion.
Importantly, the puncta formed by STIM1-Kras and STIM1-
Lyn are likely not localized in the same microdomain. First,
PM localization of STIM1-Lyn was eliminated by deletion of the
STIM1 K-domain, while STIM1-Kras was retained in the PM
puncta in spite of deletion of the K-domain (Supplementary
Fig. 6c,e). Second, STIM1-Kras strongly co-IP’ed with SARAF,
the Co-IP is independent of store depletion and it is not further
enhanced by Orai1 (Fig. 5d). On the other hand, STIM1-Lyn does
not Co-IP with SARAF regardless of the presence or absence of
Orai1 or of store depletion (Fig. 5d). It was not possible to show
the differential localization of STIM1-Kras and STIM1-Lyn in the
same cells since the strong targeting motifs of STIM1-Kras and
STIM1-Lyn recruited the respective STIM1s to the same puncta.
This is illustrated in Supplementary Fig. 5d,e showing that
STIM1-Kras and STIM1-Lyn recruited wild-type STIM1 to the
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same puncta. Nevertheless, the differential role of the K-domain
and interaction with SARAF indicate that STIM1-Kras and
STIM1-Lyn are targeted to different PM microdomains.
The STIM1-Kras and STIM1-Lyn probes were then used to
measure the FRET efficiency with SARAF under various
conditions. Figure 5a illustrates the experimental protocol. As
expected from the Co-IP results (Fig. 5d), STIM1-Lyn failed to
recruit SARAF (Fig. 5b,c) when the two were co-expressed. Co-
expression of Orai1 slightly reduced the basal STIM1-Lyn/SARAF
FRET efficiency before and after Ca2þ store depletion. Similarly,
Supplementary Fig. 7 shows that the Hras motif also targets
STIM1 to PM puncta in the absence of Ca2þ store depletion and
that STIM1-Hras failed to interact with SARAF. In sharp
contrast, STIM1-Kras/SARAF displayed high FRET efficiency,
which was maximized by the expression of Orai1 and did not
increase by store depletion (Fig. 5c). Hence, the Kras motif targets
STIM1 to a domain where it can recruit SARAF, whereas the Lyn
and Hras motifs target STIM1 to a domain that prevents the
recruitment of SARAF, although STIM1 can access Orai1 in both
domains.
The functional significance of targeting STIM1 to the different
domains is shown in Fig. 5e–g. Figure 5e shows the CRAC
current measured in the presence of the strong and fast Ca2þ
buffer 10mM BAPTA to minimize SCDI and Supplementary
Fig. 3d shows the Ca2þ permeability of cells expressing STIM1-
Kras alone. Notably, STIM1-Kras/Orai1 was largely constitutively
active independent of store depletion, while STIM1-Lyn/Orai1
was not, although both generated puncta in the absence of
store depletion (Supplementary Fig. 5). However, the store
depletion fully activated STIM1-Lyn/Orai1 and STIM1-Hras/
Orai1 with similar current density to STIM1-Kras/Orai1
(19.7±0.9, 17.8±0.4 and 18.7±0.4 pA/pF, respectively; n¼ 7,
5, 13, respectively). Most significantly, Fig. 5f,g show that the
Orai1 current activated by STIM1-Kras undergoes rapid and
strong SCDI with no further effect of SARAF, whereas the
currents activated by STIM1-Lyn and STIM1-Hras are not
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affected by SARAF. The effects of targeting STIM1 by the Kras,
Hras and Lyn motifs were not non-specific effects of extension of
the STIM1 C terminus. Extending STIM1 C terminus by a similar
size a helix had no effect on current amplitude (19.1±0.5 pA/pF;
n¼ 4) or SCDI by SARAF (Supplementary Fig. 8).
The results in Supplementary Figs 5–7 and Fig. 5 suggest that
the Kras, Hras and Lyn motifs target STIM1 to different PM
microdomains. STIM1-Kras is likely targeted to the domain
dependent on caveolin/PI(4,5)P2/E-Syt1/septins, while STIM1-
Lyn and STIM1-Hras are targeted to a different domain. STIM1-
Kras and STIM1-Lyn/Hras then recruit Orai1 to the two
respective domains. STIM1-Kras/Orai1, but not STIM1-Lyn-
Hras/Orai1, then recruits SARAF to mediate SCDI. In support of
this conclusion, the fast and maximal SCDI observed with
STIM1-Kras is eliminated by the knockdown of SARAF (Fig. 6a),
knockdown of caveolin (Supplementary Fig. 3c), depletion of
PI(4,5)P2 (Fig. 6b) and knockdown of E-Syt1 (Fig. 6c), while the
SCDI observed with STIM1-Lyn is not affected by the depletion
of PI(4,5)P2 (Fig. 6d).
Translocation of STIM1 between PI(4,5)P2 microdomains. The
above findings indicate that the STIM1–Orai1 complex must
localize to the PI(4,5)P2-rich domain to assume a conformation
that allows it to recruit SARAF and mediate SCDI. Conversely,
when the STIM1–Orai1 complex is in a PI(4,5)P2-poor domain it
is in a conformation that cannot access SARAF, and thus the
Orai1 current is more sustained. A critical question is whether
STIM1 translocates between the two domains during physiolo-
gical activation of the current. The first evidence that this is the
case can be deduced from the delayed interaction between STIM1
and SARAF (Fig. 1a,b). Direct evidence for the shift of STIM1–
Orai1 between microdomains is given in Fig. 7. We targeted
EGFP with N terminus Lyn motif or YFP with C terminus Hras
motif to the PI(4,5)P2-poor domain and YFP with C terminus
Kras motif to the PI(4,5)P2-rich domain (Fig. 7a and model in
Fig. 7b). The probes were co-expressed with CFP-STIM1, and
FRET in response to store depletion was measured. Most notably,
FRET between Lyn-EGFP (Fig. 7c) or YFP-Hras (Fig. 7d) and
CFP-STIM1 started upon start of store depletion but was tran-
sient and returned to basal levels within 1–2min. Conversely,
FRET between YFP-Kras and CFP-STIM1 started after a delay
of about 1min and then remained stable. Most notably, the
depletion of PI(4,5)P2 resulted in retention of STIM1 in the
Lyn/Hras PI(4,5)P2-poor domain and its exclusion from the Kras
PI(4,5)P2-rich domain.
Discussion
Excess Ca2þ influx is associated with, and in many cases is the
initiator of, cellular and tissue pathologies. Hence, Ca2þ influx
channels are extensively regulated, most prominently by Ca2þ
itself, to restrict Ca2þ influx. This is very well described for the
Orai1 channel, which undergoes both FCDI and SCDI3, with
STIM1 (refs 12,27–29) and SARAF (Fig. 1 and Supplementary
Fig. 1a) participating in both through the STIM1 CTID domain12.
The present work indicates that the regulation of Orai1 by Ca2þ
depends on the localization of the Orai1–STIM1 complex to
specific PM microdomains and dynamic translocation of the
complex between the microdomains; this sets the STIM1
conformation that recognizes SARAF. The microdomain is
assembled by the E-Syt1-mediated tethering of the ER to the
PM and appears to require several proteins known to demarcate
PM microdomains, such as caveolin and septins. Caveolin is a
scaffolding protein that participates in the formation of caveolae
and assembly of signalling complexes30. Septins are a family of
small GTPases that polymerize into non-polarized filaments and
interact with both microtubules and the actin cytoskeleton to
restrict distribution of proteins and lipids in the PM31. We note
that the depletion of caveolin, E-Syt1 and PI(4,5)P2 did not
reduce the Orai1 current but only eliminated the effect of SARAF
on SCDI. However, the depletion of septin4 while eliminated the
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effect of SARAF, also reduced the Orai1 current by about 36%.
This would suggest that septins have a more global role in
determining the composition and shape of the PM.
A puzzling observation in the present study is that STIM1-Lyn
and STIM1-Hras clustered at the PM but did not cause store-
independent activation of Orai1, although the store depletion
fully activated Orai1. Previous studies already concluded that
STIM1 clustering is not sufficient to activate Orai1 (refs 10,12).
However, in these cases, the STIM1 mutants were able to cluster
but not activate Orai1, whereas STIM1-Lyn and STIM1-Hras
fully activate Orai1. Moreover, when PI(4,5)P2 is depleted,
STIM1-Lyn is retained in the PI(4,5)P2-poor domain (Fig. 7)
and remains fully active. Together these findings suggest that the
store depletion does more than co-clustering STIM1–Orai1 to
activate the channel. This may be due to the dissociation of
SARAF from STIM1, or due to the stabilization of a particular
STIM1–Orai1 conformation.
The present studies reveal dynamic translocation of the
STIM1–Orai1 complex between PI(4,5)P2-poor and PI(4,5)P2-
rich microdomains to control Ca2þ influx. This is a new form of
regulation by PI(4,5)P2 that has not been previously described.
Prior modes of regulation by PI(4,5)P2, including the regulation
of ion transporters, has been attributed to a reduction or increase
in PM PI(4,5)P2 levels or to targeting of proteins to PI(4,5)P2-rich
microdomains (reviewed in ref. 32). Dynamic translocation
between PM microdomains with different PI(4,5)P2 levels
allows efficient temporal and spatial regulation independent of
PI(4,5)P2 synthesis and breakdown. Translocation back and forth
between PI(4,5)P2 microdomains should result in oscillatory
activity of the regulated proteins. In the case of Orai1–STIM1,
this will result in oscillations in Ca2þ influx to support receptor-
evoked Ca2þ oscillations.
STIM1 and SARAF are localized in the ER and interact to some
extent in the basal state with filled Ca2þ stores, as indicated by
their basal Co-IP12 (Fig. 1b) and FRET efficiency (Figs 4d and 5c
and Supplementary Fig. 2). Moreover, SARAF stabilizes STIM1 in
the basal conformation since the knockdown of SARAF resulted
in the store-independent clustering of STIM1 and Ca2þ
influx11,12. Activation of Ca2þ influx by store depletion needs
to relieve the basal inhibition of STIM1 by SARAF leading to the
formation of the STIM1–Orai1 complex. Ca2þ influx should be
sustained for some time before its reinhibition by SARAF. The
present studies provide evidence to suggest that the STIM1–Orai1
complex is first targeted to a PI(4,5)P2-poor microdomain,
where STIM1 is in a conformation that fully activates Orai1 but
minimally interacts with SARAF to increase Orai1 activity.
Subsequently, the STIM1–Orai1 complex translocates to a
PI(4,5)P2-rich microdomain (Fig. 7) formed by tethering the
ER and PM by E-Syt1 (Fig. 4). In this microdomain, STIM1 is
now in a conformation that binds SARAF, which mediates
the SCDI to limit Orai1 activity. This mechanism allows the
precise and timed regulation of Ca2þ influx between fully
activated and partially inhibited Ca2þ influx to guard against cell
toxicity.
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Methods
Constructs and antibodies. STIM1-YFP, HA-Orai1, mCherry-Orai1, the Orai1
mutants and SARAF clones have been previously described9,12. The FKBP12
and FRB constructs are described in ref. 21). CFP-STIM1, CFP-STIM1DK and
Orai1-CFP were a kind gift from Dr Murali Prakriya33. E-Syt1 was a gift from
Dr Jen Liou19 and E-Syt1, E-Syt2 and E-Syt3 were a kind gift from Dr Pietro
DeCamilli18. Primers were obtained from Integrated DNA Technologies.
All mutations were generated using the QuikChange Lightning site-directed
mutagenesis kit from Agilent Technologies. Primers used for cloning are listed in
Supplementary Table 1. Preparation of the SARAF-myc has been previously
described12. SARAF-YFP was made by digesting out SARAF at MluI and HindIII
sites and ligating into pCMVYFP plasmid. STIM1-Kras, STIM1-Lyn, STIM1-Hras
and Random a-helix constructs were made by mutating the bases in frame 5 amino
acids downstream of the STIM1 open reading frame in CFP-STIM1. In brief, CFP-
STIM1 plasmid was amplified using the specified primers and the Quick change
lightning kit from Agilent and then the backbone was digested using dpnI enzyme.
The primer sequences are shown in Supplementary Table 1: Kras-Lys Lys Lys Lys
Lys Lys Ser Lys Thr Lys Cys Val Ile Met; Lyn-Arg Asn Met Gly Cys Ileu Ser Lys Ser
Lys Arg Lys Asp; Hras-Gly Cys Met Ser Cys Lys Cys Val Leu Ser; a-helix-Ala Ala
Leu Lys Leu Ile Glu Ala Leu Ala Trp Glu Leu Ala. pYFP-Kras was made by
mutating the amino acids to the Kras motif 3 amino acids downstream from YFP
open reading frame. YFP-Hras was made by mutating the Hras motif 5 amino
acids downstream from YFP open reading frame. p3xflag-mCherry-Kras was made
by mutating to the Kras sequence 5 amino acids downstream of the open reading
frame of mCherry. Lyn-pEGFP (Cat #35958) and PLCD1 PH-EGFP (Cat #21179)
were purchased from Addgene. Antibodies used at the present work are: polyclonal
anti-GFP (Life Technologies, Cat # A11122) 1:1,000; monoclonal anti-myc (Cell
Signaling Inc., Cat # 2276) 1:1,000; polyclonal anti-SARAF (Thermo Fisher
Scientific, Cat # PIPA524237) 1:100; polyclonal anti-Cav-1 (Sigma, Cat #
C449-200) 1:500; polyclonal anti-E-syt1 (Sigma, Cat # SAB1105095) 1:250 and
polyclonal anti-Septin (Sigma, Cat # SAB2501449) 1:200.
siRNA probes and RT–PCR. The scrambled control and short interfering RNA
(siRNA) duplex sequences for SARAF, SEPTIN4, E-syt1 and Caveolin-1 are listed
in Supplementary Table 1. The siRNA sequences for E-Syt2 and E-Syt3 were the
same as those used before18. HEK293 cells were plated at 70–80% confluence and
transfected using Lipofectamine 2000 with siRNA duplexes after 12 h (20–40 nM
per well) in six-well plates in serum-free medium according to the manufacturer’s
protocol. The medium was changed to serum-containing medium 6 h after adding
the duplexes to the cells. The cells were harvested after 48 h. The cells were
harvested after 48 h. RNA was extracted using the TRIZOL reagent and the mRNA
levels were determined by quantitative PCR as described34. In brief, the isolated
mRNA was reverse transcribed into cDNA by the iscript cDNA synthesis kit from
Bio-Rad Laboratories. The primers for quantitative reverse transcriptase-PCR for
SARAF, Septin4, E-Syt1, E-syt2, E-syt3 and GAPDH were purchased from Applied
Biosystems. The fold change in the transcript levels of the specified genes was
calculated by normalizing the Ct values from control and siRNA-transfected cells
(threshold values) to GAPDH.
FRETmeasurements. HEK293 cells were plated at low confluence on glass bottom
dishes (MatTek Corporation) and transfected with ECFP (donor) and EYFP
(acceptor) tagged constructs, for 12–16 h using Lipofectamine 2000 (Invitrogen) at
37 C. FRET imaging was performed at 37 C using a confocal system (FV1000;
Olympus) equipped with UplanSApo  60 oil immersion objective (NA 1.35;
Olympus) at  1 zoom. Images were acquired at 10-s intervals using the simplified
two-cube method for sensitized emission35,36. To minimize photobleaching, low
laser power (1–3%) was used.
Image analysis was performed with NIH ImageJ software. Images were
corrected for background fluorescence as necessary. FRET was determined on a
pixel-by-pixel basis using a two-step FRET efficiency calculation protocol37. In
brief, bleed-through components were removed by generating a corrected FRET
image (Fc) according to the equation Fc¼ IDA dIDD where IDA and IDD are the
background-subtracted FRET and ECFP images, respectively. The microscope-
specific bleed-through constants a and d were determined by measuring the bleed-
through from cells expressing ECFP or EYFP alone. The derived values were
d¼ IDA/IDD¼ 0.061±0.0064 (n¼ 52 cells) and a¼ IDA/IAA¼ 0.02±0.0015
(n¼ 46 cells). In the second step, the apparent FRET efficiency (Eapp) was
calculated using the algorithm Eapp¼ Fc/(FcþGIDD) where Eapp is the fraction
of ECFP exhibiting FRET and G is a microscope-specific constant derived
by measuring the increase in ECFP fluorescence following EYFP acceptor
photobleaching with the intramolecular CFP–YFP construct YFP–OASF–CFP7,
which was estimated to be 0.69±0.12 (n¼ 18 cells).
Confocal imaging. For confocal imaging, Hela cells plated at low confluence on
glass bottom dishes were transfected with the indicated constructs for 8–12 h.
The images were captured at room temperature with UplanSApo  60 oil
immersion objective (NA 1.35; Olympus) at  4 zoom. Images were processed
with Photoshop CS3 (Adobe).
PI(4,5)P2 depletion. PM PI(4,5)P2 was depleted using the FRB/FKBP system
provided by Dr Tamas Balla (NIH) and described in refs 38,39. In brief, the PM
Lyn-targeting sequence was fused to the FRB domain of mTOR1. The wild-type or
kinetic-dead 50-phosphatase was fused to FKBP12, which was tagged with mRFP.
The two constructs were co-expressed in the cells. On exposure of the cells to
rapanycin, the FRB and the FKBP12 heterodimerize to recruit the phosphatase
to the PM and hydrolyse PI(4,5)P2.
Current measurements. HEK293T cells were cultured in Dulbecco’s modified
eagle’s medium and 10% fetal bovine serum. Lipofectamine 2000 (Invitrogen) was
used for cDNA or siRNA transfection. Treatment with siRNAs was with 20–40 nM
for 48 h and transfection with cDNA was for 24–36 h before start of current
recording. On the day of experiment, transfected cells were released and replated
on square coverslips in 35-mm petri dishes and incubated with culture media for at
least 1 h to allow attachment to the coverslips. Expression pattern and levels
of the various constructs were carefully monitored by fluorescence microscopy.
Electrophysiological experiments were performed at 20–24 C using the patch-
clamp technique in the whole-cell recording configuration. For current measure-
ments, voltage ramps of  100 to 100mV were applied every 4 s from a holding
potential of 0mV. The current at  100mV was used to calculate current density
as pA/pF.
To measure SCDI, the pipette solution contained 135mM CsCl, 6mM MgCl2,
2mM MgATP, 1.2mm EGTA and 10mm HEPES, pH 7.2 (with CsOH). During
SCDI recording, after establishing the whole-cell configuration, the cells were kept
in Ca2þ -free solution for 5min to allow store depletion before exposing the cells to
bath solution containing 10mM Ca2þ . The standard bath solution contained
130mM NaCl, 5mM KCl, 1 MgCl2 and 10mM HEPES with or without 10mM
CaCl2 (pH 7.4 with NaOH). To measure the extent of spontaneous current, the
current was recorded as above except that 10mM BAPTA replaced the 1.5mM
EGTA. Membrane potentials were amplified with an Axopatch 200B (Axon
Instruments, Foster, CA, USA). The currents were filtered at 5 kHz and displayed
on computer monitor. Where indicated, the currents were normalized first by
averaging multiple experiments and then normalizing to the peak current. Peak
currents are given in the text. Results were analysed using the Clampfit programme
(Axon Instruments) and all currents are given as mean±s.e.m.
Ca2þ measurement. Cells attached to coverslips were loaded with Fura2 by
30min incubation at 37 C with 5 mM Fura2/AM in culture media. After dye
washing, florescence was measured at 340 and 380 nm using a TILL system as
detailed before12. Collected images were analysed using MetaFluor and the results
are given as the 340/380 ratio.
Western blot and Co-IP measurements. HEK293T cells were transfected with
STIM1, SARAF and with or without Orai1. After 24 h, the cells were washed once
in Ca2þ -free solution and treated with 25 mM CPA for 0, 15, 30 or 45 s and the
reactions were stopped and lysates prepared by a rapid removal of media and
attrition of 0.5ml of lysis buffer. Lysates (100 ml) containing the same amount of
protein were cleared by incubation with 50 ml of Protein G Sepharose beads.
The cleared lysates were used to IP STIM1 with anti-myc (SARAF) antibodies by
incubation with 1 ml anti-myc antibody overnight at 4 C. The complexes
were collected by addition of 50 ml of Protein G Sepharose beads and incubation
for 4 h at 4 C. The precipitates were analysed for STIM1 (anti-GFP, 1:1,000)
and SARAF (anti-myc, 1:1,000). Uncropped blot images are shown in
Supplementary Fig. 9.
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